The SEC filing shows a total of more than $323 million raised by the brain implant maker. After Musk announced in August that Neuralink brought in $280 million, the latest investment totals around $43 million.
Neuralink develops an implant called the N1 that comes in at about the size of a coin. Remotely rechargeable, the implant goes along with electrode-laced threads that go further into the brain. Neuralink also has an R1 robot meant to be programmed to implant the BCI system while avoiding vasculature.
The company designed its system to enable the user to control a computer or mobile device anywhere they go. It garnered regulatory for a first-in-human implant in May and in September it opened up recruitment for its clinical trial.
(Neuralink featured among MassDevice’s 2022 list of seven BCI companies you need to know. We recently published a 2023 list that includes five more you should know.)
According to the SEC filing, Neuralink made its first sale in the equity offering in August. To date, the offering includes participation from 32 investors providing at least the minimum of $14,995. Neuralink did not list an intended use of proceeds for the now completed offering.
The company is still recruiting participants for its clinical trial as it looks to regain steam in the BCI space. Other competitors — including Precision Neuroscience and Synchron — have received FDA nods for trials as well.
